HOUSTON--(BUSINESS WIRE)--Power3 Medical Products, Inc. (OTCBB:PWRM), (www.power3medical.com), today announced that the Company has taken steps necessary for the commercialization of its early diagnostic tests for breast cancer, Alzheimer’s and Parkinson’s disease, and anticipates revenue from sales and licensing this quarter.
